StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lisata Therapeutics's pe ratio was 1.5× on Feb 28, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Feb 28, 20191.5×+0.1
2018Dec 31, 20181.4×–

More Lisata Therapeutics figures

See a number that looks wrong?